Indivior added to S&P SmallCap 600 index, boosting U.S. business profile
Indivior (NASDAQ:INDV) has announced its inclusion in the S&P SmallCap 600 index, effective December 22, 2025.
The company stated that this milestone aligns its capital markets presence with a sharpened U.S. business profile and supports the growth of SUBLOCADE, its first-in-class long-acting injectable for moderate to severe opioid use disorder.










